Key Record Dates
ClinicalTrials.gov Identifier: | NCT04342910 |
---|---|
Brief Title: | Study to Evaluate the Efficacy and Safety of Camrelizumab and Apatinib in Patients With GC/GEJC |
First Submitted : | April 9, 2020 |
First Submitted that Met QC Criteria : | April 10, 2020 |
First Posted : | April 13, 2020 |
Last Update Submitted that Met QC Criteria : | November 17, 2020 |
Last Update Posted : | November 18, 2020 |